简体中文 | 繁體中文 | English

Products & Services News

2026-07-09 15:13 NetApp Named Presenting Partner of 2026 NFL Madrid Game
2026-07-09 15:11 Robbyant Unveils LingBot-World 2.0: Pioneering Hour-Long Real-Time Generation in World Models
2026-07-09 11:21 QpiAI Open-Sources Its Quantum SDK to Accelerate Global Quantum Software Development
2026-07-09 10:52 Loomis Sayles Growth Equity Strategies Team Celebrates Twenty-Year Milestones
2026-07-09 10:48 Modon's Hudayriyat Golf Estates Sets UAE Record With More Than AED 13 Billion in Sales Within Days of Launch
2026-07-09 10:03 Dryad Networks Reaches XPRIZE Wildfire Finals Milestone, Demonstrating Autonomous Detection and Suppression of Wildfires in Alaska
2026-07-09 09:51 Merck Announces FDA Breakthrough Therapy Designation for Enpatoran in Lupus Patients With Active Skin Manifestations
2026-07-08 16:15 Robbyant Upgrades and Open-Sources LingBot-VLA 2.0 as a Next-Generation Universal Brain for Embodied AI
2026-07-08 16:00 Access Advance Welcomes Wave of New Licensees to the HEVC Advance Patent Pool
2026-07-08 15:56 SS&C Expands Tokenized Investment Capabilities with Digital Cash Settlement
2026-07-08 15:41 UMA Unveils Its Vision for the Next Generation of Humanoid Robots
2026-07-08 15:38 Andersen Global Adds Collaborating Firm Abcoo Law Firm
2026-07-08 15:23 Bitcoin Suisse Advances Middle East Expansion, Receiving Financial Services Permission in Abu Dhabi
2026-07-08 13:01 Capvidia Announces 2026 R1 Software Release to Strengthen MBD Readiness, QIF Workflows, and Digital Thread Automation
2026-07-08 10:39 Morinaga Milk Achieves Self-Affirmed GRAS Status for LAC-Living+™, Expanding U.S. Opportunities for Its Postbiotic Ingredient
2026-07-08 10:28 Allegro DVT Plays a Pivotal Role in Groundbreaking CHASSIS Automotive Base Die Development
2026-07-07 16:03 Robbyant Unveils LingBot-Depth 2.0 and LingBot-Vision to Redefine Robotic Spatial Perception
2026-07-07 16:00 Access Advance Welcomes New Licensors to the Video Distribution Patent Pool
2026-07-07 15:44 Agenus Reports Landmark BOT+BAL Data Showing 33% Three-Year Overall Survival in Refractory MSS Metastatic Colorectal Cancer Without Active Liver Metastases at ESMO GI 2026
2026-07-07 15:27 Orion and Shilpa Medicare Expand Partnership to Develop and Supply Nivolumab Biosimilar for Europe

Business Wire Weibo

Press Releases

Latest Releases